Concepedia

Publication | Open Access

Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related Tuberculosis

DOIFull Paper Access

155

Citations

29

References

2005

Year

William J. Burman, Debra Benator, Andrew Vernon, Awal Khan, Brenda Jones, Cláudia Silva, Chris Lahart, Stephen E. Weis, Barbara King, Bonita T. Mangura,
American Journal of Respiratory and Critical Care Medicine

Abstract

Intermittent rifabutin-based therapy for HIV-related TB was well tolerated, but there was a high risk of treatment failure or relapse with acquired rifamycin resistance among patients with low CD4 lymphocyte counts.

References

YearCitations

Page 1